Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-17Hybrid Effectiveness-Implementation Trial to Evaluate a Scalable, Peer-Delivered Intervention for Depression Among People With Substance Use Disorder in a Certified Community Behavioral Health Clinic
-
CLINICAL_TRIALS study record update · 2026-04-17Double-Blind, Single and Multiple Dose Study to Determine Pharmacodynamic Markers, Pharmacokinetic Parameters, and Safety of ALTO-203 in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-17Clinical Validation of Samsung Smartwatch
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase III, Placebo-Controlled, Randomized, Double-Blind Trial of Oral Doses of CYB003 to Assess Combined Safety and Efficacy in Humans With Major Depressive Disorder
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-15Enhancing Veteran-Clinical Collaboration in VA Psychosocial Rehabilitation and Recovery Centers
-
CLINICAL_TRIALS study record update · 2026-04-15A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2026-04-14VR-Moodboost in the Treatment of Depression; a Proof-of-concept Study
-
CLINICAL_TRIALS study record update · 2026-04-14Early TMS-EEG Potentials as Biomarkers for Personalized Neuromodulation in Treatment-Resistant Depression (R61 Phase)
-
CLINICAL_TRIALS study record update · 2026-04-13Reducing Suicide Risk in Adolescents and Young Adults Via a Psychobehavioral Intervention to Regularize Daily Rhythms and Improve Brain Circuitry Functioning
-
CLINICAL_TRIALS study record update · 2026-04-13Randomized, Cross-over, Placebo-controlled Trial to Determine Target Engagement and Dose Response of Optimized Closed-loop rTMS for Medication-resistant Depression
-
CLINICAL_TRIALS study record update · 2026-04-13Comparative Efficacy of Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-13Home-Based Cognitive Remediation and Transcranial Direct Current Stimulation to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression
-
CLINICAL_TRIALS study record update · 2026-04-13Can the Affects Conveyed by Baroque Music and Its Rhetoric Reduce Anxiety in Patients With Major Depressive Disorder Associated With Anxiety Symptoms?
-
CLINICAL_TRIALS study record update · 2026-04-13Phase 2, Multicenter, Randomized, Double-Blind Evaluation of the Efficacy and Safety of Oral GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-09Pilot Study Using Endogenous Aperiodic Brain Activity to Personalize Transcranial Alternating Current Stimulation as a Treatment for Antenatal Depression: PandA-tACS
-
CLINICAL_TRIALS study record update · 2026-04-08A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-08A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-08An Open-Label Study Evaluating the Safety and Efficacy of Ropanicant in Participants With Moderate to Severe Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-08A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-08Long-term Study to Assess the Safety and Effectiveness of NMRA-335140 in Participants With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-07A Non-Inferiority Randomized Controlled Trial Comparing Online and On-Site Cognitive Behaviour Therapy in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-06Mindfulness Engaged Neurostimulation for Depression (MEND II)
-
CLINICAL_TRIALS study record update · 2026-04-06Behavioral and Neuronal Correlates of Human Mood States
-
CLINICAL_TRIALS study record update · 2026-04-02The Carolina Recovery From Depression Protocol (CARED) : A Novel Rapid Treatment Paradigm for Depression